Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marwick

Showing results (931-940 of 984) with videos related to

Pageof 99
Sort By:
Nature Communications|August 14, 2020
A fluorogenic cyclic peptide for imaging and quantification of drug-induced apoptosisNicole D Barth, Ramon Subiros-Funosas, Lorena Mendive-Tapia, et al.
Elife|July 22, 2017
Pro-death NMDA receptor signaling is promoted by the GluN2B C-terminus independently of Dapk1Jamie McQueen, Tomás J Ryan, Sean McKay, et al.
Journal of Clinical Medicine|February 25, 2022
Incremental Value of Myocardial Work over Global Longitudinal Strain in the Surveillance for Cancer-Treatment-Related Cardiac Dysfunction: A Case-Control StudyWojciech Kosmala, Tomoko Negishi, Paaladinesh Thavendiranathan, et al.
European Heart Journal. Cardiovascular Imaging|March 30, 2018
Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imagingLuigi P Badano, Theodore J Kolias, Denisa Muraru, et al.
Journal of Diabetes and Its Complications|May 2, 2025
Health status in stage B heart failure from diabetic cardiomyopathy baseline results from ARISE-HFTariq Jamal Siddiqi, Yuxi Liu, Faiez Zannad, et al.
Circulation|February 3, 2005
Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart AssociationJennifer H Mieres, Leslee J Shaw, Andrew Arai, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 16, 2024
Absolute cardiovascular risk assessment using 'real world' clinic blood pressures compared to standardized unobserved and ambulatory methods: an observational studyNiamh Chapman, Senali Jayasinghe, Myles N Moore, et al.
American Heart Journal|June 14, 2025
STAREE-HEART: a randomized placebo-controlled trial of atorvastatin effects on a marker of cardiac aging in older individuals without prior cardiovascular disease events: Protocol and baseline description of participantsIngrid Hopper, Thomas H Marwick, Rory Wolfe, et al.
The American Journal of Cardiology|November 26, 2009
Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])Brett R Cowan, Alistair A Young, Craig Anderson, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 7, 2009
The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristicsBrett R Cowan, Alistair A Young, Craig Anderson, et al.
Pageof 99

Showing results (931-940 of 984) with videos related to

Sort By:
Pageof 99
Nature Communications|August 14, 2020
A fluorogenic cyclic peptide for imaging and quantification of drug-induced apoptosisNicole D Barth, Ramon Subiros-Funosas, Lorena Mendive-Tapia, et al.
Elife|July 22, 2017
Pro-death NMDA receptor signaling is promoted by the GluN2B C-terminus independently of Dapk1Jamie McQueen, Tomás J Ryan, Sean McKay, et al.
Journal of Clinical Medicine|February 25, 2022
Incremental Value of Myocardial Work over Global Longitudinal Strain in the Surveillance for Cancer-Treatment-Related Cardiac Dysfunction: A Case-Control StudyWojciech Kosmala, Tomoko Negishi, Paaladinesh Thavendiranathan, et al.
European Heart Journal. Cardiovascular Imaging|March 30, 2018
Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imagingLuigi P Badano, Theodore J Kolias, Denisa Muraru, et al.
Journal of Diabetes and Its Complications|May 2, 2025
Health status in stage B heart failure from diabetic cardiomyopathy baseline results from ARISE-HFTariq Jamal Siddiqi, Yuxi Liu, Faiez Zannad, et al.
Circulation|February 3, 2005
Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart AssociationJennifer H Mieres, Leslee J Shaw, Andrew Arai, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 16, 2024
Absolute cardiovascular risk assessment using 'real world' clinic blood pressures compared to standardized unobserved and ambulatory methods: an observational studyNiamh Chapman, Senali Jayasinghe, Myles N Moore, et al.
American Heart Journal|June 14, 2025
STAREE-HEART: a randomized placebo-controlled trial of atorvastatin effects on a marker of cardiac aging in older individuals without prior cardiovascular disease events: Protocol and baseline description of participantsIngrid Hopper, Thomas H Marwick, Rory Wolfe, et al.
The American Journal of Cardiology|November 26, 2009
Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])Brett R Cowan, Alistair A Young, Craig Anderson, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 7, 2009
The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristicsBrett R Cowan, Alistair A Young, Craig Anderson, et al.
Pageof 99